Skip to main content
. 2020 Aug 1;11(9):2145–2157. doi: 10.1007/s13300-020-00896-w

Table 3.

Comparative analyses of the investigated clinical parameters between T2D cases and controls, n = 400

T2D Control t test for equality of means
t Sig. (2-tailed)
N 300 100 p values
Age (years) 39.13 ± 9.51 38.11 ± 8.44 4.55 < 0.0001
BMI (kg/m2) 28.5 ± 5.2 24.8 ± 2.3 6.94 < 0.0001
FPG (mg/dl) 135.1 ± 26.0 90.2 ± 7.1 17.09 < 0.0001
PPG (mg/dl) 204.2 ± 35.9 136.2 ± 4.5 18.89 < 0.0001
HbA1c 7.1 ± 1.1 5.7 ± 0.5 12.40 < 0.0001
FPI 9.6 ± 1.4 8.7 ± 0.7 6.23 < 0.0001
Systolic BP (mmHg) 145.1 ± 17.3 106.1 ± 10.4 21.57 < 0.0001
Diastolic BP (mmHg) 102.4 ± 15.8 75.9 ± 10.9 15.84 < 0.0001
T-Cholesterol (mg/dl) 245.5 ± 15.2 152.6 ± 18.8 51.99 < 0.0001
HDL (mg/dl) 46.8 ± 11.1 46.2 ± 8.7 0.50 0.615
LDL (mg/dl) 192.3 ± 29.1 106.4 ± 19.9 27.92 < 0.0001
Triglycerides (mg/dl) 357.9 ± 99.1 141.0 ± 5.5 21.86 < 0.0001

Data presented as mean ± SD for biochemical parameters and p values calculated by Student’s t test. Significant at p < 0.05

BMI body mass index, FPG fasting plasma glucose, PPG postprandial plasma glucose, HbA1c haemoglobin A1c test, FPI fasting plasma insulin, BP blood pressure, HDL high-density lipoprotein, LDL low-density lipoprotein